Rheonix Obtains $250,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cb136dfd-140b-4b12-9a53-80d4e87be744&Preview=1 - Date
12/31/2009 - Company Name
Rheonix - Mailing Address
22 Thornwood Drive Ithaca, NY 14850 - Company Description
Rheonix, Inc. is exploiting its novel, patented, polymer chip microfluidic technology to introduce products that address some of the hottest issues in global healthcare today: Avian Influenza, HPV, TB, Dengue Fever, AIDS, SARS, bioterrorism, affordable healthcare in developing nations, personalized medicine, and molecular diagnostics, to name a few. Rheonix is not predicated on creating new science; rather its business is bringing to commercial reality the long-promised potential of integrated microfluidic systems. Its unique polymer chip microfluidic technology has produced a wide variety of fluid-handling devices including channels, pumps, reaction vessels, diagnostic chambers, and combinations thereof. - Website
http://www.rheonix.com - Transaction Type
Venture Equity - Transaction Amount
$250,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Cayuga Venture Fund - Venture Investor
Onondaga Venture Capital Fund - Venture Investor
Rand Capital - Venture Investor
Undisclosed
